Adverse cutaneous reactions to hydroxychloroquine are more common in patients with dermatomyositis than in patients with cutaneous lupus erythematosus

Archives of Dermatology

Volumn 138, Issue 9, 2002, Pages 1231-1233

  Pelle, Michelle T ^a   Callen, Jeffrey P ^a   Bigby, Michael ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; CHLOROQUINE; HYDROXYCHLOROQUINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DERMATOMYOSITIS; DRUG HYPERSENSITIVITY; ERYTHEMA; FEMALE; HIGH RISK POPULATION; HUMAN; INCIDENCE; MALE; MORBIDITY; MORTALITY; PAPULE; PRIORITY JOURNAL; PRURITUS; RASH; RISK BENEFIT ANALYSIS; SKIN LUPUS ERYTHEMATOSUS;

EID: 0036718365     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archderm.138.9.1231     Document Type: Article

References (9)

1. Dermatomyositis
2. Cutaneous lesions of dermatomyositis are improved by hydroxychloroquine
3. The treatment of dermatomyositis with hydroxychloroquine
4. Adjunctive use of hydroxychloroquine in childhood dermatomyositis
5. Amyopathic dermatomyositis, photosensitivity and hydroxychloroquine
6. Plaquenil-induced erythroderma
7. A postgraduate lecture on lupus erythematosus
8. Treatment of lupus erythematosus with mepacrine
9. Worsening of the rash of juvenile dermatomyositis with hydroxychloroquine therapy